非增强CT与CT灌注标记物对脑出血血肿扩大及预后预测的附加价值
本研究回顾性分析150例发病6小时内行非增强CT和CT灌注的原发性脑出血患者,评估血肿内低密度、形态不规则、血肿周围脑血容量及点征。基线影像标记物数量与血肿扩大(OR 2.66)和不良预后(OR 1.64)独立相关,四种标记物同时存在时预测血肿扩大和不良预后的平均概率分别为91%和79%。
要点
- 基线影像标记物数量与血肿扩大独立相关(OR 2.66,95%CI 1.70-4.17,p<0.001)。
- 四种标记物同时存在时血肿扩大和不良预后的平均预测概率分别为91%和79%。
- 至少存在一种标记物预测血肿扩大和不良预后的敏感度分别为91%和87%。
核心结论
- 非增强CT和CT灌注标记物联合分析可提高对脑出血血肿扩大和不良预后的预测能力,联合标记物分析优于单指标单独分析的敏感度。
研究设计与样本
- 回顾性单中心分析,纳入150例发病6小时内行非增强CT和CT灌注的原发性脑出血患者,中位年龄68岁,男性47.1%。
关键影像表现/征象
- 非增强CT评估血肿内低密度和形态不规则。
- CT灌注评估血肿周围脑血容量和点征。
- 四种标记物同时存在时血肿扩大和不良预后的平均预测概率分别为91%和79%。
诊断标准与关键数值
- 血肿扩大定义为增长>6 mL和/或>33%。
- 不良功能预后定义为90天改良Rankin量表评分3-6分。
- 基线影像标记物数量与血肿扩大独立相关(OR 2.66,95%CI 1.70-4.17,p<0.001)。
- 基线影像标记物数量与不良预后独立相关(OR 1.64,95%CI 1.06-2.56,p=0.027)。
- 至少存在一种标记物预测血肿扩大和不良预后的敏感度分别为91%和87%。
临床应用与阅片要点
- 联合分析非增强CT和CT灌注标记物可帮助识别血肿扩大和不良预后高风险患者。
- 包含CT灌注的多模态CT方案有助于识别临床恶化和不良预后高风险患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To test the hypothesis that the combined analysis of non-contrast CT (NCCT) and CT perfusion (CTP) imaging markers improves prediction of hematoma expansion (HE) and outcome in intracerebral hemorrhage (ICH).
METHODS: Retrospective, single-center analysis of patients with primary ICH undergoing NCCT and CTP within 6 h from onset. NCCT images were assessed for the presence of intrahematomal hypodensity and shape irregularity. Perihematomal cerebral blood volume and spot sign were assessed on CTP. The main outcomes of the analysis were HE (growth > 6 mL and/or > 33%) and poor functional prognosis (90 days modified Rankin Scale 3-6). Predictors of HE and outcome were explored with logistic regression.
RESULTS: A total of 150 subjects were included (median age 68, 47.1% males) of whom 54 (36%) had HE and 52 (34.7%) had poor outcome. The number of imaging markers on baseline imaging was independently associated with HE (odds ratio 2.66, 95% confidence interval 1.70-4.17, p < 0.001) and outcome (odds ratio 1.64, 95% CI 1.06-2.56, p = 0.027). Patients with the simultaneous presence of all the four markers had the highest risk of HE and unfavorable prognosis (mean predicted probability of 91% and 79% respectively). The combined-markers analysis outperformed the sensitivity of the single markers analyzed separately. In particular, the presence of at least one marker identified patients with HE and poor outcome with 91% and 87% sensitivity respectively.
CONCLUSION: NCCT and CTP markers provide additional yield in the prediction of HE and ICH outcome.
KEY POINTS: • Perihematomal hypoperfusion is associated with hematoma expansion and poor outcome in acute intracerebral hemorrhage. • Non-contrast CT and CT perfusion markers improve prediction of hematoma expansion and unfavorable prognosis. • A multimodal CT protocol including CT perfusion will help the identification of patients at high risk of clinical deterioration and poor outcome.
引用
- Morotti, Busto, Boulouis, et al. Added value of non-contrast CT and CT perfusion markers for prediction of intracerebral hemorrhage expansion and outcome. Eur Radiol. 2022. PMID: 35895123. doi:10.1007/s00330-022-08987-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。